Learn more

MOOGENE MEDI CO LTD

Overview
  • Total Patents
    20
  • GoodIP Patent Rank
    82,747
  • Filing trend
    ⇩ 55.0%
About

MOOGENE MEDI CO LTD has a total of 20 patent applications. It decreased the IP activity by 55.0%. Its first patent ever was published in 2016. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are BEIJING MINHAI BIOTECHNOLOGY CO LTD, CHOONG ANG VACCINE LAB and QILU ANIMAL HEALTH PRODUCTS CO.

Patent filings in countries

World map showing MOOGENE MEDI CO LTDs patent filings in countries

Patent filings per year

Chart showing MOOGENE MEDI CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Yu Kyeong Nam 9
#2 Yu Kyeong-Nam 6
#3 Ryu Jee-Yeon 4
#4 Cho Eun Yi 3
#5 Lee Han A Reum 3
#6 Yoon Tae-Jong 2
#7 Ryu Jee Yeon 2
#8 Won Eun-Jeong 2
#9 Cho Eun-Yi 2
#10 Kim Jin Hyun 2

Latest patents

Publication Filing date Title
KR101918250B1 Nanoliposome-microbubble assemblies encapsulating a durg for the treatment of androgenic alopecia, and composition comprising the same for improving or treating hair loss
KR101923199B1 Composition comprising Pepstatin A for diagnosis of EN2 in urine
KR101870694B1 Nanoliposome-microbubble assemblies encapsulating complex of Cas9 protein, guide RNA for repressing gene expression or SRD5A2 gene and cationic polymer, and composition comprising the same for improving or treating hair loss
KR101777259B1 Specific monoclonal antibody to EN2 protein or composition comprising the same for diagnosis of prostate cancer
KR101777254B1 Specific monoclonal antibody from a specific antigen EN2 protein or composition comprising the same for diagnosis of prostate cancer
KR101796036B1 Delivery carrier composition comprising nanoliposome encapsulating complex of Cas9 protein, guide RNA for repressing gene expression or KRAS gene and cationic polymer, or therapeutics comprising thereof for treating KRAS mutation colon cancer with anticancer drug resistance
KR101710026B1 Composition comprising delivery carrier of nano-liposome having Cas9 protein and guide RNA